Come up with a name for your new list and we'll add to it:
Par Pharmaceutical Companies was acquired by
Endo International on May 18, 2015.
Par Pharmaceutical Companies is a privately held, U.S.-based specialty pharmaceutical company. The company develops, manufactures and markets high-barrier-to-entry generic drugs and niche, innovative …